Branched-chain amino acids (BCAA: leucine, isoleucine and valine) are essential amino acids implicated in glucose metabolism and maintenance of correct brain function. Elevated BCAA levels can promote an inflammatory response in peripheral blood mononuclear cells. However, there are no studies analysing the direct effects of BCAA on endothelial cells (ECs) and its possible modulation of vascular function. In vitro and ex vivo studies were performed in human ECs and aorta from male C57BL/6J mice, respectively. In ECs, BCAA (6 mmol/L) increased eNOS expression, reactive oxygen species production by mitochondria and NADPH oxidases, peroxynitrite formation and nitrotyrosine expression. Moreover, BCAA induced pro-inflammatory responses through the transcription factor NF-κB that resulted in the release of intracellular adhesion molecule-1 and E-selectin conferring endothelial activation and adhesion capacity to inflammatory cells. Pharmacological inhibition of mTORC1 intracellular signalling pathway decreased BCAAinduced pro-oxidant and pro-inflammatory effects in ECs. In isolated murine aorta, BCAA elicited vasoconstrictor responses, particularly in pre-contracted vessels and after NO synthase blockade, and triggered endothelial dysfunction, effects that were inhibited by different antioxidants, further demonstrating the potential of BCAA to induce oxidative stress with functional impact. In summary, we demonstrate that elevated BCAA levels generate inflammation and oxidative stress in ECs, thereby facilitating inflammatory cells adhesion and endothelial dysfunction.
| INTRODUCTION
Branched-chain amino acids (BCAA: leucine, isoleucine and valine) are essential amino acids which are important components of proteins in human skeletal muscles. 1 BCAA also modulate glucose metabolism 2 and contribute to the maintenance of correct brain function. 3 Therefore, BCAA are used as supplements in states of malnutrition to prevent muscular cachexia in critical and oncological patients. 4 In addition, these amino acids are commonly used at high doses as nutritional supplements to potentially improve mental and physical performance and with the purpose of muscle building. 5, 6 However, there are not solid performed studies about the potential toxicity of excessive or chronic BCAA supplementation.
Increased BCAA plasma concentrations have been found in several pathological conditions such as Maple syrup urine disease (MSUD) 7 and type 2 diabetes (T2DM) and obesity. [8] [9] [10] Importantly, highly elevated BCAA blood concentrations in MSUD patients are responsible for neurological damage, 11 and in T2DM and obesity, elevated BCAA blood concentrations are associated with insulin resistance 10, 12 and were suggested as important predictors of future diabetes and positively associated with enhanced cardiovascular risk. 13, 14 In fact, some authors proposed BCAA as biomarkers for vascular complications such as subclinical atherosclerosis or coronary artery disease. 15 However, the mechanisms involved are rather poorly understood.
Chronic low-grade inflammation 16, 17 and oxidative stress 18, 19 are major pathophysiological mechanisms involved in T2DM, obesity and atherosclerosis leading to insulin resistance, endothelial dysfunction and micro-and macro-vascular complications.
Increased reactive oxygen species (ROS) generation induces endothelial dysfunction by impairing the bioactivity of endothelial NO and promotes leucocyte adhesion, inflammation, thrombosis and smooth muscle cell proliferation-all processes that exacerbate atherosclerosis. NADPH oxidase and mitochondria are key sources of vascular oxidative stress involved in endothelial dysfunction in several cardiovascular pathologies. 20 , 21 We recently demonstrated that in cultured human peripheral blood mononuclear cells (PBMC), high BCAA concentration promotes oxidative stress from NADPH oxidase and mitochondria, the release of pro-inflammatory cytokines mediated by the activation of the nuclear transcription factor-κB (NF-κB) and the migration of PBMC via the activation of the mammalian target of rapamycin (mTORC1) axis. 22 However, whether this also occurs in endothelial cells (ECs), and whether it might contribute to endothelial dysfunction, is unknown.
In this study, we hypothesized that BCAA-derived ROS and inflammation might be important contributors of abnormal vascular function. Therefore, we evaluated the direct effects of high BCAA levels on ECs and aorta and the possible mechanisms involved in such effects with particular emphasis on ROS generation and inflammation.
| MATERIALS AND METHODS

| Cell culture
Human vascular ECs were isolated from the macroscopically healthy part of intact saphenous veins harvested from patients undergoing high ligation of varicose veins as described. 23 The veins were rinsed with PBS 1×, opened longitudinally to expose the endothelium and put it in direct contact with enzyme solution containing 1 mg/mL of collagenase type I (Gibco) for 30 minutes at 37°C in a humidified atmosphere of CO 2 (5%). After the digestion step, the upper face of endothelium was scraped to detach the ECs. Then, cells were centrifuged and seeded on gelatin 0.5% 
| NADPH oxidase activity assay
The O 2 ·− production generated by NADPH oxidase activity was determined by a chemiluminescence assay, as described. 22 Briefly, In some experiments, mouse aortic segments were pre-incubated in the organ bath with N-nitro-L-arginine methyl ester (L-NAME, 0.1 mmol/L) in the absence or presence of gp91dstat, ML171, mito-TEMPO or celecoxib (1 μmol/L) before the BCAA concentration-response curves. These segments were not pre-contracted with phenylephrine. These drugs were added 30 minutes before L-NAME.
To demonstrate a possible direct effect of BCAA on vascular smooth muscle cells we performed experiments where the endothelium was mechanically removed. Concentration-response curves to BCAA in phenylephrine pre-contracted vessels or in arteries incubated or not with L-NAME were performed as described above.
In another set of experiments, aortic segments were exposed to 
| Immunohistochemistry
OCT-embedded aortic segments were stained using standard histology procedures. Immunostaining was carried out in 3-μm-thick tissue sections and fixed using phosphate-buffered 4% paraformaldehyde.
Endogenous peroxidase was blocked and aorta sections were incu- 
| Fluorimetric peroxynitrite assay
Peroxynitrite levels were measured in supernatants from aortic segments exposed to BCAA in the absence or presence of gp91dstat
and ML171 in DMEM-F12 Ham for 24 hour as described above, found in some individuals if consumed daily 6-20 g BCAA for 2 months in 2 or 3 cycles per year or for uninterrupted period of time. 5, 6 As shown in Figure 1A PI3K/Akt pathway is as an upstream activator of mTORC1 in different cell types. 22, 27, 28 In ECs, BCAA promoted Akt phosphorylation ( Figure 1D ). Interestingly, both the mTORC1 inhibitor rapamycin ZHENYUKH ET AL. 
| BCAA trigger NF-κB pro-inflammatory pathway in ECs
A positive relationship between oxidative stress generation and activation of the pro-inflammatory NF-κB pathway has been described in different clinical conditions. 29 One of the earliest events in NF-κB 
| BCAA induce leucocyte adhesion to endothelium
The adhesion of monocytes to endothelial cells is considered one of the initial events in endothelial dysfunction in vascular pathologies. 31, 32 In our recent study, high levels of BCAA induced PBMC migration 22 and herein we observed increased expression of adhesion molecules in ECs in response to BCAA. Thus, we next investigated the effect of BCAA on PBMC adhesion to ECs. As shown in To demonstrate the contribution of vascular smooth muscle cells to BCAA-induced contraction, we performed experiments where the endothelium was mechanically removed. As shown in Figure 5E , in endothelium-denuded arteries pre-contracted with phenylephrine BCAA still induced a contractile response. However, this contractile response was not observed neither in basal conditions nor in arteries incubated with L-NAME ( Figure 5F ), suggesting that endothelium-F I G U R E 4 BCAA promote leucocytes adhesion to endothelium. Effect of BCAA (6 mmol/L, 1 h) on leucocytes adhesion to ECs pre-incubated with or without rapamycin (RAPA), AICAR, wortmannin (W), mito-TEMPO (MITO), gp91dstat (dstat), ML171 (ML) and BAY-11-7082 (BAY). Data are expressed as mean ± SEM. ***P < .001 vs Control (C). ≠ P < .05; ≠≠ P < .01 vs BCAA. n = 7 dependent and -independent mechanisms are responsible for BCAAinduced contraction. They also suggest complex mechanisms of smooth muscle contraction in response to BCAA as pre-contraction seems to be needed to achieve contraction.
| BCAA induce endothelial dysfunction through ROS production
Oxidative stress is a well-known promoter of endothelial dysfunction. 33 We next evaluated the effect of long exposure (24 hour) to ) is shown in C, together with the effect of gp91dstat, ML171 and mito-TEMPO on concentration-response curves to BCAA in aortic segments pre-contracted with phenylephrine. D, Effect of gp91dstat, ML171, mito-TEMPO and celecoxib on BCAA-induced contractile responses in aortic segments incubated with L-NAME (100 μmol/L, 30 min) without phenylephrine pre-contraction. Concentration-response curves to BCAA in aorta without endothelium (E-) precontracted with phenylephrine (E) or incubated with L-NAME without phenylephrine pre-contraction (F). Data represent mean ± SEM. ***P < .001 vs Control. Excessive O 2 ·− can react with NO increasing peroxynitrite levels, a potent oxidant that leads to the nitration of tyrosine residues in tissue proteins. Accordingly, BCAA incubation increased aortic protein levels of nitrotyrosine and peroxynitrite formation that were prevented by ML171 and gp91dstat ( Figure 7A,B) . Together, these results suggest that BCAA impairs NO availability, rather than NO signalling in vascular smooth muscle cells, by increasing ROS levels mainly from NADPH oxidase.
| DISCUSSION
The main findings of our study are that high BCAA concentrations can trigger oxidative stress and NF-κB activation and inflammation in ECs and in the vasculature thus likely contributing to the endothelial dysfunction and cardiovascular disease frequently observed in different pathological conditions associated to elevated BCAA levels.
There are few data about the relationship between elevated BCAA plasma levels and inflammation. In MSUD patients, high BCAA blood concentrations cause neurological damage associated with sustained inflammation including elevated serum levels of IL-1β, IL-6
and IFN-γ. 34 In normoglycemic women, insulin resistance was associated with increased serum BCAA concentrations, down-regulation of mitochondrial energy metabolism and increased expression of inflammation-related genes (CCL2-CCL5) in the adipose tissue. 35 Finally, our recent study demonstrated that elevated concentrations of BCAA induced inflammation and oxidative stress in PBMC. 22 Our results in ECs further support the role of BCAA as mediators of inflammation and ROS production and provide novel important information that connects this systemic and local inflammatory milieu with vascular damage. Thus, BCAA trigger ROS generation from NADPH oxidases and mitochondria and also promote a pro-inflammatory response characterized by increased NF-κB activation and subsequent up-regulation of inflammatory molecules such as iNOS and the adhesion molecules ICAM-1 and E-selectin, which facilitate inflammatory cell migration 22 and adhesion to ECs (present study).
Interestingly, mitochondrial ROS was responsible at least in part, for the NF-κB activation, but this transcription factor did not influence ROS generation in response to BCAA, suggesting that alternative pathways exist for BCAA-induced oxidative stress. Our data are in contrast with those published by D'Antona et al, 36 showing improved mitochondria biogenesis and decreased ROS production together with increased antioxidant defenses in middle-aged (16 months old) mice supplemented with a BCAA enriched mixture during 3 months. However, this approach is clearly different from the acute effects of BCAA evaluated in our study. It is also important to highlight that in this study, 36 the levels of BCAA reached in plasma after 3 months of BCAA supplementation are unknown and this might be an important issue in the context of local exposure to BCAA. Finally, HL-1 cardiomyocytes were treated with a BCAA enriched mixture that included 11 different amino acids which differ from the 3 amino acids mixture used in our study. 36 BCAA act as strong nutrient signals mainly activating mTORC1
to promote cell growth, proliferation, migration, inflammation and oxidative stress in cancer cells 27, 37 and PBMC. 22 We found that in
ECs BCAA also promoted concentration-dependent phosphorylation of mTORC1 and activation of Akt. Interestingly, mTORC1 was able to modulate Akt activation, suggesting the existence of a cross-talk between both signalling pathways. More importantly, the effects of BCAA on ROS generation, NF-κB activation, inflammatory genes expression and leucocytes adhesion to ECs, were blunted by rapamycin. This highlights the pivotal role of mTORC1 in mediating prooxidant and pro-inflammatory effects of BCAA on ECs, and it might be in agreement with the role of the overactivation of Akt-mTORC1
axis and the progression of the metabolic syndrome, future development of T2DM and the associated endothelial cell activation and endothelial dysfunction. [37] [38] [39] The molecular mechanisms responsible for the mTOR-dependent activation of NOX and NF-κB in response to BCAA are unknown and this is a limitation of our study. However, other authors have also found a role for mTOR in oxidative stress generation 40, 41 or NF-κB activation in response to different stimuli or pathological conditions. 42, 43 Besides mTORC1, BCAA trigger several signalling responses via the activation of AMPK, which plays a role in cellular energy homoeostasis. We suggest that the upstream activation of AMPK could be a tool to limit the activation of mTORC1 in response to BCAA. This is in line with previous studies in other cell types showing that AMPK can prevent mTORC1 activation. 44 In turn, this mechanism might prevent, at least in part, downstream mTORC1-induced ROS production, inflammation and cell adhesion. In agreement, an AMPK activator AICAR, is able to decrease these parameters in response to BCAA.
It is well accepted that unbalanced ROS production actively participate in alterations of vascular tone associated with various diseases, such as hypertension, diabetes or atherosclerosis. 33, 45 The major sources of ROS at vascular level are NADPH oxidase and mitochondria. [46] [47] [48] Our data provide a proof-of-concept of the potential harmful effect of BCAA in the vascular endothelium. However, the physiological relevance of the concentrations of BCAA and times of exposure used in the present study remain to be established. Thus, the pro-oxidant and inflammatory effects of BCAA were observed at concentrations that could be reached in MSUD 7, 27 or in daily BCAA supplementation in sportsmen, 5, 6 but higher than those found in patients suffering from obesity or diabetes. 8, 9 However, it is important to highlight that lower concentrations of BCAA (0.5-2 mmol/L) already increased vascular contraction which might add physiological relevance. On the other hand, chronic exposure to moderately elevated BCAA levels added to hyperglycaemia and pro-inflammatory conditions decrease the threshold of mTOR phosphorylation and increase ROS formation in PBMC 27,37 and we cannot discard that this mechanism might be also operating in endothelial cells.
Together, our findings provide mechanistic and functional evidence linking elevated levels of BCAA and endothelial dysfunction.
We demonstrate that elevated BCAA levels produce inflammation and oxidative stress in endothelial cells via mTORC1 pathway, therefore facilitating inflammatory cells adhesion. In turn, this pro-oxidant and inflammatory milieu facilitate vascular hypercontractility and F I G U R E 7 BCAA induce nitrotyrosine expression and increase peroxynitrite levels. Effect of BCAA (6 mmol/L, 24 h) pre-incubated 30 min with or without ML171 and gp91dstat (dstat) on A, protein nitrosylation levels in aortic sections and B, peroxinytrite levels measured in supernatants from aortic segments. Data are expressed as mean ± SEM. *P < .05 vs Control (C). 
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